BNP PARIBAS FINANCIAL MARKETS - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 108 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,260,258
+25.8%
61,506
+22.0%
0.00%
+100.0%
Q2 2023$1,002,124
-50.9%
50,434
-57.7%
0.00%
-66.7%
Q1 2023$2,040,577
+81.8%
119,123
+107.7%
0.00%
+50.0%
Q4 2022$1,122,222
-100.0%
57,344
-69.0%
0.00%
-60.0%
Q3 2022$2,949,232,000
+1133.4%
184,789
+963.4%
0.01%
Q2 2022$239,108,000
-75.8%
17,377
-72.1%
0.00%
-100.0%
Q1 2022$986,254,000
-3.4%
62,185
+32.9%
0.00%0.0%
Q4 2021$1,021,491,000
+257.0%
46,793
+388.8%
0.00%
Q3 2021$286,137,000
-94.7%
9,573
-92.1%
0.00%
-100.0%
Q2 2021$5,361,039,000
+1223.0%
121,044
+1225.3%
0.01%
+600.0%
Q1 2021$405,231,000
+39.0%
9,133
+71.8%
0.00%0.0%
Q4 2020$291,529,000
+49.3%
5,316
-37.8%
0.00%
Q3 2020$195,247,000
+171.7%
8,541
+148.7%
0.00%
Q2 2020$71,874,000
-58.4%
3,434
-72.3%
0.00%
Q1 2020$172,771,000
+119.7%
12,385
+258.5%
0.00%
Q4 2019$78,636,000
+64.8%
3,455
-15.6%
0.00%
Q3 2019$47,707,000
+20.1%
4,095
+54.6%
0.00%
Q2 2019$39,720,000
-54.2%
2,648
-46.4%
0.00%
Q1 2019$86,648,000
+416.0%
4,940
+624.3%
0.00%
Q3 2018$16,791,000
+11.4%
682
-11.2%
0.00%
Q2 2018$15,076,000
+79247.4%
768
+76700.0%
0.00%
Q1 2018$19,00010.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders